World News: 16:51 GMT Friday 10th May 2019. [Teva Pharmaceutical Industries Ltd. via Businesswire via SPi World News]
Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA today announced the launch of aversion of Delzicol1 mesalamine delayed-release 400 mg in the US Mesalamine Delayed-Release Capsule s are a...
Business Wire: 16:51 GMT Friday 10th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.